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Employment Opportunities
Postdoctoral Fellowship in Statistical Genetics.—The Asthma
Genetics Laboratory (AGL) at the University of California,
San Francisco (UCSF), is inviting applications for postdoc-
toral fellows to participate in projects aimed at understand-
ing the genetic basis of complex diseases in racially admixed
populations. The AGL is a member of UCSF’s Institute for
Human Genetics and has a highly interactive and multi-
disciplinary team of physician-scientists, genetic epidemi-
ologists, statisticians, geneticists, and molecular biologists.
The research environment is enhanced by large, family-
based and population-based sample sets of well phenoty-
ped, racially diverse individuals and strong national and
international collaborative ties. The successful candidate
will participate in development of statistical methods, study
design, and data analysis for genomewide association stud-
ies, studies of population stratification, and investigations
of admixture mapping for complex diseases. A suitable can-
didate will hold a Ph.D. in a quantitative science (statistics,
biostatistics, computer science, or mathematics) or epide-
miology and should have strong theoretical, analytical, and
computational skills. A background in genetic epidemiol-
ogy and statistical genetics would be beneficial. An ability
to work collaboratively and good communication skills are
required. Applicants should email a curriculum vitae and a
letter of application and should arrange for three or more
letters of reference to be sent to Dr. Esteban Gonzalez Bur-
chard, M.D., M.P.H., Director, Asthma Genetics Laboratory
and UCSF DNA Bank (esteban@sfgh.ucsf.edu). UCSF is an
affirmative action/equal opportunity employer.
Program Director, Genetic Counseling.—The Division of Hu-
man Genetics at the University of California, Irvine (UCI),
is conducting a search for a program director, who will be
responsible for the continuing development and super-
vision of our innovative accredited graduate program in
genetic counseling. The Division serves the genetic coun-
seling needs of our diverse community, and the graduate
program dynamically interacts with other units within the
University, such as the UCI Chao Family Comprehensive
Cancer Center, the Division of Maternal-Fetal Medicine,
and the programs in nursing science, public health, and
pharmaceutical science. It is required that the director be
board certified in genetic counseling. The successful appli-
cant should have 10 years experience as a practicing ge-
netic counselor, as well as a significant background in
teaching, research, and/or administration. UCI offers acom-
petitive salary and excellent benefits and pension plans, as
well as an ideal location in southern California, close to
beaches and mountains. UCI is an equal opportunity em-
ployer. For further information, please contact Virginia
Kimonis, M.D., Chief, Division of Genetics and Metabo-
lism Department of Pediatrics, UCI Medical Center, 101
The City Drive South, ZC4482, Orange, CA 92868; tele-
phone: (714) 456-5791, direct: (714) 456-2942; fax: (714)
456-5330; e-mail: vkimonis@uci.edu. Also, administrative
assistant Sara Davis-Eisenman can be reached by tele-
phone at (714) 456-6612.
Fellowship in Medical Genetics & Pediatric Endocrinology.—
The Heritable Disorders Branch of the National Institute
of Child Health & Human Development (NICHD) is spon-
soring a combined medical genetics and pediatric endo-
crinology fellowship that will lead to certification by both
the American Board of Medical Genetics and the American
Board of Pediatrics Sub-Board on Pediatric Endocrinology
after 5–6 years of training (and approval by each Board).
Clinical training will take place in the context of the
ACGME-approved Pediatric Endocrinology and Medical
Genetics fellowship programs of the National Institutes of
Health (NIH) and will be sponsored by the NICHD and
the National Human Genome Research Institute (NHGRI).
Graduates of a pediatrics or combined pediatrics/inter-
nal medicine ACGME-approved residency program in the
United States who are either citizens or legal residents
(green-card holders) of this country are eligible. We en-
courage applicants with previous Ph.D. training or grad-
uates of an M.D./Ph.D. program to apply for this unique
fellowship, which aims at bridging these two very relevant
subspecialties of pediatric medicine: genetics and endo-
crinology. This is an exciting opportunity for a physician-
scientist in training who wants to take advantage of the
exciting opportunities offered by the NIH Clinical Center,
the hundreds of state-of-the-art research laboratories on
the NIH campus, and the commitment of NIH leadership
in training initiatives on translational research. Interested
candidates should send a cover letter, a curriculum vitae,
and the names of at least three references to Constantine
A. Stratakis, M.D., D.Med.Sci., Chief, Heritable Disorders
Branch, NICHD, NIH, and Director, Pediatric Endocrinol-
ogy Training Program, NICHD, NIH, 10 Center Drive, Build-
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ing 10, Room 9D42, MSC 1830, Bethesda, MD 20892; tele-
phone: (301) 496-6683; fax: (301) 480-0378; e-mail: stratakc
@mail.nih.gov. For more information, see the Fellowship’s
Web site (http://www.pediatricendocrinology.nichd.nih
.gov/index.html) or call Janet Krasnican at (301) 496-6683.
Conference
Lysosomal Disease Network: WORLD (We’re Organizing Re-
search on Lysosomal Diseases) Symposium 2008.—The Ly-
sosomal Disease Network invites you to attend Lysosomal
Disease Network: WORLD Symposium 2008, February 13–
15, 2008, at the Venetian Hotel in Las Vegas. Participants
will include clinicians, geneticists and genetic counselors,
neurologists and neuropsychologists, researchers, nurses,
and other health care professionals, as well as patients and
families, patient/family support organizations, and indus-
try professionals. The Lysosomal Disease Network is a re-
search consortium of scientists, laboratories, health care
professionals, and clinics working as networked centers of
excellence to improve basic knowledge and understanding
of lysosomal disorders, improve diagnosis, and advance
therapeutic options for individuals affected by these dis-
orders. Topics will include Newborn Screening, New Ad-
vances and Therapies in Gaucher Disease, Fabry Disease,
Mucopolysaccharidosis, Batten Disease, Pompe Disease,
Mucolipidosis, Sphingolipidoses, and Oligosaccharido-
sis. American Medical Association Physician’s Recog-
nition Award Category 1 Credits will be offered; final
determination of credits is pending. For more infor-
mation, see the Lysosomal Disease Network Web site
(http://www.LysosomalDiseaseNetwork.org) or the Uni-
versity of Minnesota’s Continuing Medical EducationWeb
site (http://www.cmecourses.umn.edu) or contact the
University of Minnesota by calling (612) 626-7600 or (800)
776-8636, or by e-mail (cme@umn.edu).
Call for Patients
2q37 Deletion Syndrome and Albright Hereditary Osteodys-
trophy-Like Syndrome.—We are recruiting patients to par-
ticipate in an institutional review board-approved study,
entitled “Molecular Delineation of the 2q37 Deletion
Syndrome,” through Dr. Micheala Aldred’s lab in the Ge-
nomic Medicine Institute at the Cleveland Clinic. Pa-
tients are eligible for enrollment with (1) a diagnosed
2q37 deletion or a translocation involving this chro-
mosomal region or (2) a clinical diagnosis of 2q37 de-
letion syndrome or Albright Hereditary Osteodystrophy
in the absence of GNAS mutations and pseudohypopar-
athyroidism. Participants will be asked to give a blood
or DNA sample, copies of medical records, and family his-
tory information. For more information, please contact
Emily Edelman by telephone (216-444-8088) or e-mail
(edelmae@ccf.org) or visit our Web site (http://www
.lerner.ccf.org/gmi/research.php#b2q37).
